相似文献
1
Origin and bioactivities of thiosulfinated FK228.
Medchemcomm. 2019 Mar 25;10(4):538-542. doi: 10.1039/c9md00060g. eCollection 2019 Apr 1.
2
Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228.
Synth Syst Biotechnol. 2018 Nov 5;3(4):268-274. doi: 10.1016/j.synbio.2018.10.011. eCollection 2018 Dec.
3
High-yield production of FK228 and new derivatives in a Burkholderia chassis.
Metab Eng. 2023 Jan;75:131-142. doi: 10.1016/j.ymben.2022.12.002. Epub 2022 Dec 15.
4
Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.
J Nat Prod. 2011 Oct 28;74(10):2031-8. doi: 10.1021/np200324x. Epub 2011 Jul 27.
5
Improved production of cytotoxic thailanstatins A and D through metabolic engineering of MSMB43 and pilot scale fermentation.
Synth Syst Biotechnol. 2016 Apr 1;1(1):34-38. doi: 10.1016/j.synbio.2016.02.002. eCollection 2016 Mar.
6
[Inhibitory effect of a novel histone deacetylases inhibitor FK228 on human colon cancer HCT-116 cells in vitro and in vivo].
Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):814-8.
7
Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines.
J Pharmacol Exp Ther. 2005 Jul;314(1):467-75. doi: 10.1124/jpet.105.083956. Epub 2005 Apr 15.
8
Global analysis of histone lysine acetylation and proteomic changes in EC109 cells treated with the histone deacetylase inhibitor FK228.
Oncol Lett. 2018 May;15(5):7973-7980. doi: 10.3892/ol.2018.8312. Epub 2018 Mar 21.
9
Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Invest New Drugs. 2007 Feb;25(1):31-40. doi: 10.1007/s10637-006-9000-0.
10
Inhibition of class I HDACs attenuates renal interstitial fibrosis in a murine model.
Pharmacol Res. 2019 Apr;142:192-204. doi: 10.1016/j.phrs.2019.02.011. Epub 2019 Feb 23.
本文引用的文献
1
Genomics-guided discovery of a new and significantly better source of anticancer natural drug FK228.
Synth Syst Biotechnol. 2018 Nov 5;3(4):268-274. doi: 10.1016/j.synbio.2018.10.011. eCollection 2018 Dec.
2
Antibacterial Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate Derived from spp. against Gram-Negative and Gram-Positive Multidrug-Resistant Bacteria Isolated from Human Samples.
Biomed Res Int. 2018 Sep 17;2018:7861207. doi: 10.1155/2018/7861207. eCollection 2018.
3
Synergistic Effect of Simvastatin and Romidepsin on Gamma-globin Gene Induction.
Cell J. 2019 Jan;20(4):576-583. doi: 10.22074/cellj.2019.5589. Epub 2018 Aug 1.
4
Mechanistic studies of DepR in regulating FK228 biosynthesis in Chromobacterium violaceum no. 968.
PLoS One. 2018 Apr 19;13(4):e0196173. doi: 10.1371/journal.pone.0196173. eCollection 2018.
5
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.
Oncotarget. 2017 Dec 17;9(3):3908-3921. doi: 10.18632/oncotarget.23386. eCollection 2018 Jan 9.
6
Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.
Cell Host Microbe. 2018 Jan 10;23(1):14-26. doi: 10.1016/j.chom.2017.12.004.
7
In vitro toxicological assessment of an organosulfur compound from Allium extract: Cytotoxicity, mutagenicity and genotoxicity studies.
Food Chem Toxicol. 2017 Jan;99:231-240. doi: 10.1016/j.fct.2016.12.007. Epub 2016 Dec 8.
8
Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer.
Molecules. 2016 Nov 23;21(11):1608. doi: 10.3390/molecules21111608.
9
Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.
Biomed Chromatogr. 2017 Jan;31(1). doi: 10.1002/bmc.3807. Epub 2016 Sep 13.
10
Use of class I histone deacetylase inhibitor romidepsin in combination regimens.
Leuk Lymphoma. 2016 Aug;57(8):1755-65. doi: 10.3109/10428194.2016.1160082. Epub 2016 Apr 27.
Zotero 插件